Diffuse Bio develops generative AI for protein design, enabling the engineering of new proteins with exceptional control and precision.
Employees
10
Founded
2022
Revenue
$1.5M
Company Stage
Seed
Investors
- Y Combinator
- GreatPoint Ventures
- Fellows Fund
YC Batch
W23
Product Features & Capabilities
generative AI for protein design, Diffuse StructGen-1 (DSG-1) for designing nanobody binders, achieving a hit rate of 3%, capable of designing strong binders in the <=10nM range, computational design of therapeutics, vaccines, and enzymes, overcoming limitations of existing computational protein des